Elanco Animal Health (ELAN) Tops Q4 EPS by 1c, Offers FY Guidance

Elanco Animal Health (NYSE: ELAN) reported Q4 EPS of $0.29, $0.01 better than the analyst estimate of $0.28. Revenue for the quarter came in at $799.3 million versus the consensus estimate of $805.66 million.

GUIDANCE:

Elanco Animal Health sees FY2019 EPS of $1.02-$1.12, versus the consensus of $1.09. Elanco Animal Health sees FY2019 revenue of $3.1-3.16 billion, versus the consensus of $3.14 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• DBS Group Downgrades RoboSense Technology (2498:HK) to Hold
• Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance